All In MedTech

Device Trial Radar · NCT04581304

The Use of Bio-Oss Collagen for Sinus Augmentation Using the Transcrestal Approach.

Last checked: Nov 19, 2026Latest source record: Nov 19, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

36

Actual

Start

Oct 15, 2020

Primary completion

Dec 17, 2026

Study completion Jan 17, 2028

Sponsor

Lead sponsor
Rambam Health Care CampusAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Oct 9, 2020

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (participant)
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 18 years, up to 100 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

To assess vertical bone height gain with Geistlich Bio-Oss Collagen used in conjunction with simultaneous implant installation in transcrestal approach sinus augmentation.

Conditions

  • Bone Loss
  • Missing Teeth

Interventions

  • Geistlich Bio-Oss® CollagenDevice

    Geistlich Bio-Oss® Collagen is intended to be used for filling bone defects and for bone augmentation.

  • Geistlich Bio-Oss® GranulesDevice

    Geistlich Bio-Oss® Granules is intended to be used for filling bone defects and for bone augmentation.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Vertical bone height. (mm)Changes in augmented bone after transcrestal approach sinus augmentation.Time frame: Pre op; immediately post-op, at 6 months and 3 years from second stage surgery.

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Rambam Health Care Campus, Dept. of Periodontology

    Haifa, Israel

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.